Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,390.00
+220.00 (3.07%)
At close: Apr 23, 2026

Finemedix Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
38,66440,72878,252---
Market Cap Growth
-20.45%-47.95%----
Enterprise Value
35,90538,43580,482---
Last Close Price
7120.007500.0014410.00---
PS Ratio
4.064.287.86---
PB Ratio
2.032.143.77---
P/TBV Ratio
2.052.163.79---
P/OCF Ratio
--458.48---
EV/Sales Ratio
3.774.048.08---
EV/EBITDA Ratio
--93.59---
Debt / Equity Ratio
0.210.210.190.340.480.66
Debt / EBITDA Ratio
--4.572.3318.71-
Debt / FCF Ratio
---4.11--
Net Debt / Equity Ratio
-0.14-0.14-0.310.130.260.41
Net Debt / EBITDA Ratio
1.711.71-7.540.8810.04-3.31
Net Debt / FCF Ratio
0.790.7915.271.55-1.41-5.03
Asset Turnover
0.360.360.440.550.420.35
Inventory Turnover
1.241.241.471.901.912.60
Quick Ratio
3.583.584.261.691.210.99
Current Ratio
5.305.305.372.481.851.47
Return on Equity (ROE)
-9.44%-9.44%-0.14%9.72%2.15%-14.49%
Return on Assets (ROA)
-6.15%-6.15%-0.37%2.94%-2.13%-7.00%
Return on Invested Capital (ROIC)
-15.97%-16.90%-0.95%6.06%-3.63%-16.03%
Return on Capital Employed (ROCE)
-11.30%-11.30%-0.60%5.70%-4.50%-14.40%
Earnings Yield
-4.86%-4.61%-0.03%---
FCF Yield
-9.02%-8.56%-0.54%---
Buyback Yield / Dilution
-12.35%-12.35%-5.42%-1.75%-38.53%-9.53%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.